Members |
targetComponentId |
Dressing - item |
Wound dressing (physical object) |
Dressing of burn |
Application of dressing for burn |
Dressing of ulcer |
Dressing of ulcer (procedure) |
Dressing of wound |
Dressing of wound |
Dressing, device |
Wound dressing (physical object) |
Dressmaker |
Dressmaker |
Dribbling from mouth |
Dribbling from mouth |
Dribbling of urine |
Dribbling of urine |
Dried plasma injection |
Dried plasma injection |
Drill |
Surgical drill |
Drinks beer and spirits |
Drinks beer and spirits |
Drinks wine |
Drinks wine (finding) |
Driver's mate |
Driver's mate (occupation) |
Driving licence application signed |
Driving license application signed (finding) |
Driving licence application signed |
Driving license application signed (finding) |
Driving licence medical examination |
Driving license medical examination (procedure) |
Driving-related medical examination |
Driving-related medical examination |
Dromostanolone |
Drostanolone propionate (substance) |
Droperidol [anesthesia] |
Product containing droperidol (medicinal product) |
Droperidol [central nervous system use] |
Product containing droperidol (medicinal product) |
surdose de dropéridol d'intention indéterminée |
Droperidol overdose |
intoxication par le dropéridol d'intention indéterminée |
Droperidol poisoning |
Dropped beats - pulse |
Pulse missed beats |
Drowning |
Drowning |
Drug &/or toxic polyneuropathy |
Toxic polyneuropathy |
Drug Rx stopped - end of trial |
Drug treatment stopped at end of clinical trial (situation) |
Drug addict re-notific due |
Drug addict re-notific due |
Drug administration |
Management of drug regimen |
Drug antiserum |
Product containing antiserum (product) |
Drug capsule |
A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. |
Drug compliance aid requested |
Drug compliance aid requested |
Drug compliance aid requested |
Drug compliance aid requested |
Drug compliance good |
Drug compliance good |
Drug cream |
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. |
Drug declined by patient |
Drug declined by patient (situation) |
Drug dosage altered |
Drug dosage altered |
Drug dose - time changed |
Drug dose - time changed (finding) |
fièvre médicamenteuse |
Drug-induced hyperpyrexia (finding) |
Drug gel |
A semi-solid dose form consisting of a hydrophilic gel. |
Drug granules |
A solid dose form consisting of dry aggregates of powder particles that are sufficiently resistant to withstand handling. |
Drug indicated |
Drug indicated (situation) |
Drug indicated |
Drug indicated (situation) |
Drug intake observed |
Drug intake observed |
Drug interaction |
Drug interaction |
Drug of abuse screen on urine |
Drugs of abuse urine screening test |
Drug ointment |
A semi-solid dose form consisting of a single-phase in which solids or liquids may be dissolved or dispersed in the base, which may be hydrophilic, hydrophobic or water-emulsifying. |
Drug overdose - suicide |
Suicide by drug overdose (event) |
Drug phototoxic response |
Phototoxic drug eruption |
Drug preparation |
Type of drug preparation |
Drug prescription |
Prescription of drug |
Drug preservative |
Drug preservative |
Drug prophylaxis |
Administration of prophylactic drug or medicament (procedure) |
Drug prophylaxis |
Administration of prophylactic drug or medicament (procedure) |
Drug radioimmunoassay |
Drug radioimmunoassay (procedure) |
Drug reaction - diuretic |
Diuretic adverse reaction |
Drug reaction - diuretic |
Diuretic adverse reaction |
Drug reaction to anticonvulsant |
Antiepileptic adverse reaction |
Drug reaction to anticonvulsant |
Antiepileptic adverse reaction |
Drug suppository |
A solid single-dose form of active substance(s) dispersed or dissolved in a suitable basis that may be soluble or dispersible or may melt at body temperature. |
Drug therapy discontinued |
Drug therapy discontinued (situation) |
Drug therapy discontinued |
Drug therapy discontinued (situation) |
Drug treatment not indicated |
Drug treatment not indicated |
Drug treatment unknown |
Drug treatment unknown |
Drug user |
Misuses drugs |
excipient |
Drug vehicle |
Drug withdrawal syndrome in neonate of dependent mother |
Neonatal abstinence syndrome |
Drug withdrawal syndrome in newborn |
Neonatal abstinence syndrome |
Drug-associated neutropenia |
Drug-induced neutropenia |
Drug-induced autoimmune haemolytic anaemia |
Drug-induced autoimmune hemolytic anemia |
Drug-induced chorea |
Drug-induced chorea |
Drug-induced constipation |
Drug-induced constipation |
Drug-induced diabetes mellitus |
Drug-induced diabetes mellitus |
Drug-induced dystonia |
Drug-induced dystonia |
Drug-induced enzyme deficiency anemia |
Drug-induced enzyme deficiency anemia |
érythème médicamenteux |
Erythroderma caused by drug |
Drug-induced erythroderma |
Erythroderma caused by drug |
Drug-induced folate deficiency anemia |
Folate deficiency anaemia, drug-induced |
Drug-induced hypomelanosis |
Drug-induced hypomelanosis |
Drug-induced hypotension |
Drug-induced hypotension |
Drug-induced immune hemolytic anemia |
Drug-induced autoimmune hemolytic anemia |
Drug-induced immune hemolytic anemia, autoantibody type |
Drug-induced autoimmune hemolytic anemia |
Drug-induced malabsorption |
Malabsorption caused by drug |
Drug-induced myelopathy |
Drug-induced myelopathy |
Drug-induced myopathy |
Drug-induced myopathy |
Drug-induced osteoporosis |
Drug-induced osteoporosis |
Drug-induced parkinsonism |
Parkinsonism caused by drug |
Drug-induced pseudolymphomatous eruption |
Pseudolymphomatous eruption caused by drug |
Drug-induced pseudoporphyria |
Drug-induced pseudoporphyria |
Drug-induced psychosis |
Drug-induced psychosis |
pustoloderma tossico farmaco-indotto |
A rare hypersensitivity reaction with characteristics of the rapid development of numerous, nonfollicular, sterile, pinhead-sized pustules on an erythematous base, predominantly occurring on the trunk, intertriginous and flexural areas, with rare, mostly oral, mucosal involvement. Fever, peripheral blood leukocytosis, and mild eosinophilia are accompanying features. Systemic involvement, with hepatic, renal or pulmonary dysfunction, occasionally occurs. Onset usually occurs 1-12 days after administration of the causal medication and is most frequently associated with beta‐lactam antibiotics, macrolides (including pristinamycin and clindamycin), diltiazem, terbinafine, (hydroxy‐)chloroquine but many other medications have also been implicated. Histology reveals spongiform, subcorneal and/or intraepidermal, pustules but this pattern is not specific (same in pustular psoriasis). |
Drug-induced tremor |
Medication-induced postural tremor |
Drugs for hypoglycemia |
Product containing glucagon (medicinal product) |
Drugs in pregnancy advice |
Drugs in pregnancy education (procedure) |
Drugs not issued |
Drugs not issued |
Drugs of abuse screening |
Drug of abuse screen |
Drugs of abuse screening |
Drug of abuse screen |
Drugs of abuse screening test |
Drug of abuse screen |
Drugs of abuse screening test |
Drug of abuse screen |
Drugs of abuse screening test |
Drug of abuse screen |
Drugs of abuse urine screening |
Drugs of abuse urine screening test |
Drugs of abuse urine screening |
Drugs of abuse urine screening test |